Dap Health, INC.
Dap Health, INC. was paid $70.33M by Medicaid between Jan 2018 and Dec 2024, across 156 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 80% of everything it billed.
CATHEDRAL CITY, CA 92234
Next to other Family Medicine Physician providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 71,856 | $13.96M | |
| 2019 | 93,309 | $12.01M | |
| 2020 | 139,414 | $9.03M | |
| 2021 | 152,362 | $10.68M | |
| 2022 | 106,085 | $8.01M | |
| 2023 | 104,543 | $8.31M | |
| 2024incomplete | 64,273 | $8.32M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 80% | 294,735 | 251,188 | $55.92M |
| 00003 | Internal/system code - not a standard HCPCS code | 20% | 56,762 | 44,957 | $14.02M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 115,559 | 102,531 | $157K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 15,131 | 13,975 | $73K |
| 0012A | <1% | 833 | 481 | $26K | |
| 0011A | <1% | 738 | 446 | $20K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 18,930 | 17,125 | $17K |
| 0071A | <1% | 382 | 379 | $15K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 3,525 | 3,375 | $13K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 976 | 947 | $11K |
| 0072A | <1% | 254 | 254 | $10K | |
| 0001A | <1% | 251 | 208 | $10K |
144 more codes
| J3490 | Unclassified drugs | <1% | 337 | $5K |
| 0002A | <1% | 115 | $5K | |
| 0064A | <1% | 100 | $4K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 604 | $4K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 9,073 | $3K |
| 0004A | <1% | 44 | $2K | |
| 99000 | <1% | 14,394 | $1K | |
| G9920 | Screening performed and negative | <1% | 474 | $1K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 5,420 | $1K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 6,382 | $1K |
| 81025 | <1% | 1,570 | $930.15 | |
| 0031A | <1% | 31 | $920.00 | |
| 90677 | <1% | 164 | $879.57 | |
| 92552 | <1% | 9,660 | $609.40 | |
| 0054A | <1% | 15 | $600.00 | |
| 0052A | <1% | 12 | $480.00 | |
| 90697 | <1% | 779 | $437.34 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 4,548 | $383.81 |
| 90670 | <1% | 3,868 | $310.83 | |
| 90651 | <1% | 2,190 | $308.67 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 9,812 | $284.39 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,528 | $272.31 |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 4,716 | $241.78 |
| 57410 | <1% | 264 | $222.72 | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 80 | $189.23 |
| 90686 | <1% | 6,133 | $187.89 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 15,954 | $161.98 |
| 99384 | <1% | 321 | $131.56 | |
| 90633 | <1% | 2,112 | $128.11 | |
| 90715 | <1% | 1,044 | $113.41 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 554 | $108.80 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 713 | $102.90 |
| 83655 | <1% | 1,994 | $98.00 | |
| 85018 | <1% | 7,678 | $88.66 | |
| 86580 | <1% | 1,105 | $56.70 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 723 | $53.01 |
| 81003 | <1% | 2,247 | $50.30 | |
| 99382 | <1% | 209 | $46.66 | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 25 | $46.61 |
| 99381 | <1% | 1,049 | $45.33 | |
| 90734 | <1% | 1,321 | $36.00 | |
| 90710 | <1% | 902 | $30.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 618 | $29.81 |
| 90696 | <1% | 732 | $27.75 | |
| 90723 | <1% | 2,295 | $24.00 | |
| 99441 | <1% | 993 | $21.42 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 834 | $20.97 |
| 90681 | <1% | 1,527 | $18.00 | |
| 90716 | <1% | 779 | $18.00 | |
| 92551 | <1% | 1,553 | $11.13 | |
| 90707 | <1% | 620 | $9.00 | |
| 96160 | <1% | 23,649 | $6.42 | |
| 99173 | <1% | 10,898 | $2.54 | |
| 90619 | <1% | 429 | $2.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 26,264 | $0.92 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 172 | $0.66 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 358 | $0.56 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 44 | $0.14 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 798 | $0.12 |
| 72100 | 0% | 48 | $0.00 | |
| 90461 | 0% | 664 | $0.00 | |
| G8780 | Counseling for diet and physical activity performed | 0% | 25 | $0.00 |
| 90473 | 0% | 1,154 | $0.00 | |
| S9470 | Nutritional counseling, dietitian visit | 0% | 1,492 | $0.00 |
| 73610 | 0% | 59 | $0.00 | |
| 90700 | 0% | 525 | $0.00 | |
| G9276 | Documentation that patient is a current tobacco user | 0% | 70 | $0.00 |
| 90791 | Psychiatric diagnostic evaluation | 0% | 285 | $0.00 |
| FLUVF | 0% | 81 | $0.00 | |
| 82948 | 0% | 253 | $0.00 | |
| S0613 | Annual gynecological examination; clinical breast examination without pelvic evaluation | 0% | 738 | $0.00 |
| 99201 | 0% | 205 | $0.00 | |
| 99188 | 0% | 94 | $0.00 | |
| 90832 | Psychotherapy session, about 30 minutes | 0% | 1,732 | $0.00 |
| 83037 | 0% | 27 | $0.00 | |
| 71046 | Radiologic examination, chest; 2 views | 0% | 196 | $0.00 |
| S0610 | Annual gynecological examination, new patient | 0% | 554 | $0.00 |
| 86328 | 0% | 131 | $0.00 | |
| 73110 | 0% | 38 | $0.00 | |
| VFC | 0% | 98 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 898 | $0.00 |
| 03 | Instill, bupivac and meloxic | 0% | 26 | $0.00 |
| 90713 | 0% | 61 | $0.00 | |
| 99442 | 0% | 214 | $0.00 | |
| 73562 | 0% | 96 | $0.00 | |
| L1902 | Ankle orthosis, ankle gauntlet or similar, with or without joints, prefabricated, off-the-shelf | 0% | 12 | $0.00 |
| 3078F | 0% | 28 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 13 | $0.00 |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 53 | $0.00 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 30 | $0.00 |
| 73630 | 0% | 128 | $0.00 | |
| 1033F | 0% | 16 | $0.00 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 32 | $0.00 |
| 73130 | 0% | 85 | $0.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 68 | $0.00 |
| J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | 0% | 26 | $0.00 |
| G8511 | Screening for depression documented as positive, follow-up plan not documented, reason not given | 0% | 29 | $0.00 |
| 92550 | 0% | 14 | $0.00 | |
| Z6400 | 0% | 24 | $0.00 | |
| 99001 | 0% | 110 | $0.00 | |
| 81002 | 0% | 13 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 3,416 | $0.00 |
| 99205 | Prolong outpt/office vis | 0% | 25 | $0.00 |
| 1220F | 0% | 1,214 | $0.00 | |
| Z1032 | 0% | 147 | $0.00 | |
| 3351F | 0% | 1,390 | $0.00 | |
| 90688 | 0% | 65 | $0.00 | |
| 90647 | 0% | 2,124 | $0.00 | |
| H0033 | Oral medication administration, direct observation | 0% | 2,783 | $0.00 |
| G9275 | Documentation that patient is a current non-tobacco user | 0% | 914 | $0.00 |
| Z1034 | 0% | 1,896 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 111 | $0.00 |
| 90620 | 0% | 368 | $0.00 | |
| 81005 | 0% | 12 | $0.00 | |
| 81000 | 0% | 352 | $0.00 | |
| D1330 | 0% | 477 | $0.00 | |
| 1031F | 0% | 1,138 | $0.00 | |
| A9150 | Non-prescription drugs | 0% | 161 | $0.00 |
| G9226 | Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) | 0% | 235 | $0.00 |
| 99383 | 0% | 362 | $0.00 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 129 | $0.00 |
| Z6410 | 0% | 26 | $0.00 | |
| 59430 | 0% | 95 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 855 | $0.00 |
| HOSPO | 0% | 40 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 87 | $0.00 |
| J7626 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg | 0% | 63 | $0.00 |
| 1000F | 0% | 152 | $0.00 | |
| 99385 | 0% | 85 | $0.00 | |
| A7015 | Aerosol mask, used with dme nebulizer | 0% | 222 | $0.00 |
| 20610 | 0% | 12 | $0.00 | |
| G9008 | Coordinated care fee, physician coordinated care oversight services | 0% | 92 | $0.00 |
| H0049 | Alcohol and/or drug screening | 0% | 46 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 21 | $0.00 |
| 1036F | 0% | 110 | $0.00 | |
| 93000 | 0% | 12 | $0.00 | |
| 90792 | Psychiatric diagnostic evaluation with medical services | 0% | 105 | $0.00 |
| 90474 | 0% | 13 | $0.00 | |
| 3074F | 0% | 24 | $0.00 | |
| 90744 | 0% | 16 | $0.00 | |
| 90698 | 0% | 14 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 50 | $0.00 |
| 90634 | 0% | 15 | $0.00 | |
| 36416 | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Dap Health, INC. | Desert Hot Springs, CA | $462.99M |
| Dap Health, INC. | El Cajon, CA | $270.21M |
| Dap Health, INC. | Escondido, CA | $28.57M |
| Dap Health, INC. | Borrego Springs, CA | $18.74M |
| Dap Health, INC. | Anza, CA | $16.63M |
| Dap Health INC. | Palm Springs, CA | $10.90M |
| Dap Health, INC. | Thermal, CA | $4.18M |
| Dap Health, INC. | Coachella, CA | $4.01M |
| Dap Health, INC. | Desert Hot Springs, CA | $1.57M |
| Dap Health, INC. | La Mesa, CA | $1K |
| Dap Health, INC. | San Jacinto, CA | $705.05 |
| Dap Health, INC. | Vista, CA | $452.70 |
| Dap Health, INC. | Palm Springs, CA | $60.97 |
| Dap Health, INC. | Desert Hot Springs, CA | $0.01 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.